(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis
Public ClinicalTrials.gov record NCT00932737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled, Randomized, Parallel-group Pilot Study of the Efficacy and Safety of Oral Doses of 20 mg Hyoscine Butylbromide When Used on Demand for the Treatment of Self-reported Functional Abdominal Pain Associated With Cramping
Study identification
- NCT ID
- NCT00932737
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- HBB 20 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2009
- Primary completion
- Feb 7, 2010
- Completion
- Feb 7, 2010
- Last update posted
- May 2, 2022
2009 – 2010
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 202.839.01014 Boehringer Ingelheim Investigational Site | Westlake Village | California | — | — |
| 202.839.01003 Boehringer Ingelheim Investigational Site | Hollywood | Florida | — | — |
| 202.839.01001 Boehringer Ingelheim Investigational Site | Jupiter | Florida | — | — |
| 202.839.01002 Boehringer Ingelheim Investigational Site | Jupiter | Florida | — | — |
| 202.839.01017 Boehringer Ingelheim Investigational Site | Rockford | Illinois | — | — |
| 202.839.01005 Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| 202.839.01019 Boehringer Ingelheim Investigational Site | Chevy Chase | Maryland | — | — |
| 202.839.01009 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 202.839.01004 Boehringer Ingelheim Investigational Site | Lebanon | New Hampshire | — | — |
| 202.839.01011 Boehringer Ingelheim Investigational Site | Toms River | New Jersey | — | — |
| 202.839.01008 Boehringer Ingelheim Investigational Site | Lake Success | New York | — | — |
| 202.839.01015 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 202.839.01021 Boehringer Ingelheim Investigational Site | Norman | Oklahoma | — | — |
| 202.839.01010 Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| 202.839.01013 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 202.839.01006 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 202.839.01012 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 202.839.01007 Boehringer Ingelheim Investigational Site | Virginia Beach | Virginia | — | — |
| 202.839.01020 Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00932737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00932737 live on ClinicalTrials.gov.